Agios Pharmaceuticals: Q1 Earnings Insights

Agios Pharmaceuticals AGIO reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Agios Pharmaceuticals beat estimated earnings by 3.87%, reporting an EPS of $-1.74 versus an estimate of $-1.81.

Revenue was up $832.00 thousand from the same period last year.

Last quarter the company missed on EPS by $0.05 which was followed by a 5.7% increase in the share price the next day.

Here's a look at Agios Pharmaceuticals's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-1.69	-1.59	-1.41	-1.32
EPS Actual	-1.74	-1.56	-1.44	-1.31
Revenue Estimate	560.00K	2.60M	2.48M	44.60M
Revenue Actual	0	0	0	0

To track all earnings releases for Agios Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar